Inferact’s founding team includes computer science professor and Databricks co-founder Ion Stoica. He is currently the ...

Novel embolic device designed to obstruct or reduce blood flow, Funded by Strategic Investor. DENVER, Oct. 24, 2025 /PRNewswire/ -- Polyembo, a privately held medical device company founded to develop ...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B) a global leader in life science research and clinical diagnostics products, today announced a collaboration agreement with Oncocyte Corporation (Nasdaq ...

A Cincinnati-based technology company plans to commercialize its technology creating 3D models of X-rays and MRI scans for ...

LG Energy Solution is gearing up to commercialize a cutting-edge battery manufacturing technology that has so far evaded Tesla. It is positioning itself to intensify competition against its Chinese ...

BioLineRx Ltd. (BLRX), a commercial-stage biopharmaceutical company, and Ayrmid Ltd., the parent company of Gamida Cell Ltd (GMDA), have entered into an exclusive license agreement to commercialize ...

Under the multi-year agreement, the companies will use Guardant's portfolio of liquid and tissue biopsy tests to help enroll patients in Merck's global clinical studies.

ZURICH, Dec. 4, 2025 /PRNewswire/ -- Neurimmune today announced that it has expanded on its transthyretin amyloid cardiomyopathy (ATTR-CM) collaboration with Alexion, AstraZeneca Rare Disease by ...

(RTTNews) - Zealand Pharma A/S (ZEAL) announced a global collaboration and license agreement with Roche (RHHBY) to develop petrelintide, Zealand Pharma's amylin analog. The two companies will ...

HAWTHORNE, Calif.--(BUSINESS WIRE)--Hgen, a company that makes clean hydrogen to decarbonize heavy industry, today announced the close of a $5M seed financing round. The raise was led by Seven Seven ...